MedTech Conference 2020 Review
Review published in MTAA Annual Report.

More than 300 MedTech professionals from Australia and around the world attended the MedTech20 conference over an extensive three-day program from
26 – 28 October 2020.
The annual conference brought together industry leaders, innovators, academics, policy-makers, researchers and clinicians to share their insights, experiences and achievements in the new and cuttingedge MedTech helping to improve the lives of Australians.
This year’s conference, which was held virtually due to the ongoing COVID-19 pandemic, included seventeen sessions for attendees to choose from.
The MedTech20 conference has led by example during the pandemic, demonstrating how the MedTech industry has quickly adapted to the challenges posed by COVID-19, not just with the reformatted virtual MedTech2020 conference, but also with the once in a 100-year effort the MedTech industry as a whole has undertaken with the Government to coordinate Australia’s response to the pandemic.
Minister for Health, the Hon. Greg Hunt MP opened the conference by “acknowledging the profound role of the medical device and technology sector in helping Australia through COVID in a way very few other countries have been able to achieve.”
This year’s conference also featured a who’s who of industry leaders and experts, including:
- Dr Sarah Aitken, Vascular & Endovascular Surgeon, Concord Repatriation General Hospital and Clinical Academic, University of Sydney
- Mr Andrew Frye, Senior Vice President & President, APAC, Baxter Healthcare, Chairman of APACMed
- Adj. Prof. John Skerritt, Deputy Secretary, Health Products Regulation Group, Therapeutic Goods Administration